Recurrent Vulvovaginal Candidosis and Cluster Analysis of Clinical Signs and Symptoms: A Laboratory-Based Investigation

Recurrent Vulvovaginal Candidosis and Cluster Analysis of Clinical Signs and Symptoms: A Laboratory-Based Investigation

Recurrent vulvovaginal candidosis (RVVC) represents a major health problem that significantly affects a patient’s quality of life (QoL). This infection presents with a plethora of clinical manifestation, and this is the first study that carries out a cluster analysis of these signs and symptoms (SS)...

Full description

Bibliographic Details
Main Authors:	Aleksandra Ignjatović, Valentina Arsić-Arsenijević, Milan Golubović, Saša Đenić, Stefan Momčilović, Aleksandra Trajković, Marina Ranđelović, Vojislav Ćirić, Suzana Otašević
Format:	Article
Language:	English
Published:	MDPI AG 2020-07-01
Series:	Journal of Fungi
Subjects:	<i>Candida</i> recurrent vulvovaginal candidiasis quality of life signs and symptoms cluster analysis
Online Access:	https://www.mdpi.com/2309-608X/6/3/113

Similar Items

Phenotypic Characterization and Antifungal Susceptibility Pattern to Fluconazole in Candida species Isolated from Vulvovaginal Candidiasis in a Tertiary Care Hospital
by: Latha Ragunathan, et al.
Published: (2014-05-01)

Sertaconazole in the treatment of vulvovaginal candidiasis
by: Z. N. Efendieva
Published: (2019-10-01)

Vulvovaginal Candidosis: Current Concepts, Challenges and Perspectives
by: Valentina Sustr, et al.
Published: (2020-11-01)

Recurrent Vulvovaginal Candidiasis: An Immunological Perspective
by: Diletta Rosati, et al.
Published: (2020-01-01)

Frequency and Etiology of Vulvovaginal Candidiasis in Women Referred to a Gynecological Center in Babol, lran
by: Seddigheh Esmaeilzadeh, et al.
Published: (2009-08-01)

Population level of main microbiota and yeast-like Candida fungi in women with vulvovaginal candidiasis
by: N. D. Yakovychuk, et al.
Published: (2017-06-01)

Vulvovaginal Candidiasis: A Current Understanding and Burning Questions
by: Hubertine M.E. Willems, et al.
Published: (2020-02-01)

Three cases of vulvovaginal candidiasis due to Candida nivariensis
by: Phuong Anh Ton Nu, et al.
Published: (2024-03-01)

Modern concepts of etiopathogenesis and approaches to the treatment of recurrent vulvovaginal candidiasis
by: Margarita R. Rakhmatulina
Published: (2023-10-01)

Lamisil versus clotrimazole in the treatment of vulvovaginal candidiasis
by: Ali Zarei Mahmoudabadi, et al.
Published: (2013-03-01)

Estimation of Immunoglobulins and complements and Using Enzyme linked Immuno sorbant Assay in Identification of Vulvovaginal candidiasis
by: Baghdad Science Journal
Published: (2009-09-01)

Antifungal Activity and Type of Interaction of <i>Melissa officinalis</i> Essential Oil with Antimycotics against Biofilms of Multidrug-Resistant <i>Candida</i> Isolates from Vulvovaginal Mucosa
by: Marina Ranđelović, et al.
Published: (2023-11-01)

Isolation and identification of Candida Species in Patients with Vulvovaginal Candidiasis
by: Lakshmi Krishnasamy, et al.
Published: (2018-12-01)

Glycogen Metabolism in Candida albicans Impacts Fitness and Virulence during Vulvovaginal and Invasive Candidiasis
by: Jian Miao, et al.
Published: (2023-04-01)

Identification of Candida species associated with vulvovaginal candidiasis by Multiplex PCR method
by: Mahmoudi Rad M, et al.
Published: (2009-12-01)

Molecular identification and antifungal susceptibility profile of yeast from vulvovaginal candidiasis
by: Yu Shi, et al.
Published: (2020-04-01)

The profile of the expression of the immune response genes in the vagina of women in the complex therapy of recurrent vulvovaginal candidiasis
by: Sh M Pogosyan, et al.
Published: (2017-06-01)

Use of fluconazole in women of reproductive age with vulvovaginal candidiasis
by: E. A. Mezhevitinova, et al.
Published: (2018-09-01)

Evaluation of incidence and prevention of vulvovaginitis in juvenile stage: Professional article
by: Koledin Slađana, et al.
Published: (2016-01-01)

Species distribution and antifungal susceptibility to vulvovaginal Candida spp. in southern Mato Grosso State, Brazil
by: Letícia S. Goulart, et al.

Investigation of the Effect of Gold Nanoparticles on Vital Factors of Isolated Candida albicans in Patients with Vulvovaginal Candidiasis In Vitro
by: J Alipoor, et al.
Published: (2015-06-01)

Determination of prevalancy and Species of vulvovaginal Candidiasis and clinical findings corrolation
by: Gharaei A, et al.
Published: (2015-06-01)

Therapeutic Potential of Perillaldehyde in Ameliorating Vulvovaginal Candidiasis by Reducing Vaginal Oxidative Stress and Apoptosis
by: Lei Chen, et al.
Published: (2022-01-01)

Antifungal Activity of Linear and Disulfide-Cyclized Ultrashort Cationic Lipopeptides Alone and in Combination with Fluconazole against Vulvovaginal <i>Candida</i> spp.
by: Paulina Czechowicz, et al.
Published: (2021-09-01)

Identification of Candida species Isolated From Vulvovaginal Candidiasis Patients by Chromgen agar and PCR-RFLP Method
by: Baghdad Science Journal
Published: (2016-06-01)

Vulvovaginitis and vaginosis treatment: clinical and laboratory efficiency
by: V N Prilepskaya, et al.
Published: (2013-08-01)

Analysis of molecular resistance to azole and echinocandin in Candida species in patients with vulvovaginal candidiasis
by: Ensieh Lotfali, et al.
Published: (2022-06-01)

Vulvovaginal candidiasis therapy in reproductive age women
by: Т. Г. Романенко, et al.
Published: (2020-10-01)

The Prevalence of Non-albicans Candida and Candida Mixed-species in Vulvovaginal Candidiasis in Northeast Iran
by: Batoul Jannati, et al.
Published: (2024-03-01)

In Vitro Evaluation of Corn Silk Extract as a Potential Alternative Therapy for Vulvovaginal Candidiasis
by: Liberty P., et al.
Published: (2023-12-01)

Interspecies differences of candida species causing recurrent vulvovaginal candidiasis in response to fluconazole treatment
by: Siamak Naji, et al.
Published: (2017-07-01)

Treatment of vulvovaginal candidiasis in preparation programs for in vitro fertilization
by: A. Yu. Romanov, et al.
Published: (2021-10-01)

Efficacy and safety of ibrexafungerp in the treatment of vulvovaginal candidiasis: A meta-analysis of randomized controlled trials
by: Rong He, et al.
Published: (2024-04-01)

Molecular Identification of Candida species isolated from patients with vulvovaginitis for the first time in Mashhad
by: Zahra Kord, et al.
Published: (2017-06-01)

Prevalence of Closely Related Candida albicans Species among Patients with Vulvovaginal Candidiasis in Southern Poland Based on the hwp1 Gene Amplification
by: KLESIEWICZ KAROLINA, et al.
Published: (2023-03-01)

Differentiated approach to the treatment of various forms of vulvovaginal candidiasis
by: T Yu Pestrikova, et al.
Published: (2014-06-01)

Comparative Fungicidal Activities of N-Chlorotaurine and Conventional Antiseptics against <i>Candida</i> spp. Isolated from Vulvovaginal Candidiasis
by: Mayram Hacioglu, et al.
Published: (2022-06-01)

An Update on the Roles of Non-<em>albicans</em> <em>Candida</em> Species in Vulvovaginitis
by: Olufunmilola Makanjuola, et al.
Published: (2018-10-01)

Investigation of the relationship between different Candida species and some risk factors affecting the incidence of Vulvovaginal Candidiasis
by: Seyedeh Sedigheh Hosseini, et al.
Published: (2019-09-01)

Ibrexafungerp for the Treatment of Vulvovaginal Candidiasis: Design, Development and Place in Therapy
by: Phillips NA, et al.
Published: (2023-02-01)